Cargando…
Metabolic Signatures in Coronary Artery Disease: Results from the BioHEART-CT Study
Despite effective prevention programs targeting cardiovascular risk factors, coronary artery disease (CAD) remains the leading cause of death. Novel biomarkers are needed for improved risk stratification and primary prevention. To assess for independent associations between plasma metabolites and sp...
Autores principales: | Vernon, Stephen T., Tang, Owen, Kim, Taiyun, Chan, Adam S., Kott, Katharine A., Park, John, Hansen, Thomas, Koay, Yen C., Grieve, Stuart M., O’Sullivan, John F., Yang, Jean Y., Figtree, Gemma A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145337/ https://www.ncbi.nlm.nih.gov/pubmed/33922315 http://dx.doi.org/10.3390/cells10050980 |
Ejemplares similares
-
Lipidomics Profiling and Risk of Coronary Artery Disease in the BioHEART-CT Discovery Cohort
por: Zhu, Dantong, et al.
Publicado: (2023) -
Biobanking for discovery of novel cardiovascular biomarkers using imaging-quantified disease burden: protocol for the longitudinal, prospective, BioHEART-CT cohort study
por: Kott, Katharine A, et al.
Publicado: (2019) -
Association of Global Coagulation Profiles With Cardiovascular Risk Factors and Atherosclerosis: A Sex Disaggregated Analysis From the BioHEART‐CT Study
por: Kott, Katharine A., et al.
Publicado: (2021) -
A hierarchical approach to removal of unwanted variation for large-scale metabolomics data
por: Kim, Taiyun, et al.
Publicado: (2021) -
Serum Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1) Is Associated with Atherosclerosis Severity in Coronary Artery Disease
por: Kott, Katharine A., et al.
Publicado: (2023)